Copyright Reports & Markets. All rights reserved.

Global Blood Transfusion Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Blood Transfusion Diagnostics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Blood Transfusion Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 ELISA
    • 1.4.3 NAT
    • 1.4.4 Western Blot Assays
    • 1.4.5 Fluorescence Assay
    • 1.4.6 Other Technology
  • 1.5 Market by Application
    • 1.5.1 Global Blood Transfusion Diagnostics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Blood Banks
    • 1.5.5 Laboratories
    • 1.5.6 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Blood Transfusion Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Blood Transfusion Diagnostics Growth Trends by Regions
    • 2.2.1 Blood Transfusion Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Blood Transfusion Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Blood Transfusion Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Blood Transfusion Diagnostics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Blood Transfusion Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Blood Transfusion Diagnostics Players by Market Size
    • 3.1.1 Global Top Blood Transfusion Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Blood Transfusion Diagnostics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Blood Transfusion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Blood Transfusion Diagnostics Market Concentration Ratio
    • 3.2.1 Global Blood Transfusion Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Blood Transfusion Diagnostics Revenue in 2019
  • 3.3 Blood Transfusion Diagnostics Key Players Head office and Area Served
  • 3.4 Key Players Blood Transfusion Diagnostics Product Solution and Service
  • 3.5 Date of Enter into Blood Transfusion Diagnostics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Blood Transfusion Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Blood Transfusion Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Blood Transfusion Diagnostics Market Size by Application (2015-2020)
  • 5.2 Global Blood Transfusion Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Blood Transfusion Diagnostics Market Size (2015-2020)
  • 6.2 Blood Transfusion Diagnostics Key Players in North America (2019-2020)
  • 6.3 North America Blood Transfusion Diagnostics Market Size by Type (2015-2020)
  • 6.4 North America Blood Transfusion Diagnostics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Blood Transfusion Diagnostics Market Size (2015-2020)
  • 7.2 Blood Transfusion Diagnostics Key Players in Europe (2019-2020)
  • 7.3 Europe Blood Transfusion Diagnostics Market Size by Type (2015-2020)
  • 7.4 Europe Blood Transfusion Diagnostics Market Size by Application (2015-2020)

8 China

  • 8.1 China Blood Transfusion Diagnostics Market Size (2015-2020)
  • 8.2 Blood Transfusion Diagnostics Key Players in China (2019-2020)
  • 8.3 China Blood Transfusion Diagnostics Market Size by Type (2015-2020)
  • 8.4 China Blood Transfusion Diagnostics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Blood Transfusion Diagnostics Market Size (2015-2020)
  • 9.2 Blood Transfusion Diagnostics Key Players in Japan (2019-2020)
  • 9.3 Japan Blood Transfusion Diagnostics Market Size by Type (2015-2020)
  • 9.4 Japan Blood Transfusion Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Blood Transfusion Diagnostics Market Size (2015-2020)
  • 10.2 Blood Transfusion Diagnostics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Blood Transfusion Diagnostics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Blood Transfusion Diagnostics Market Size by Application (2015-2020)

11 India

  • 11.1 India Blood Transfusion Diagnostics Market Size (2015-2020)
  • 11.2 Blood Transfusion Diagnostics Key Players in India (2019-2020)
  • 11.3 India Blood Transfusion Diagnostics Market Size by Type (2015-2020)
  • 11.4 India Blood Transfusion Diagnostics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Blood Transfusion Diagnostics Market Size (2015-2020)
  • 12.2 Blood Transfusion Diagnostics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Blood Transfusion Diagnostics Market Size by Type (2015-2020)
  • 12.4 Central & South America Blood Transfusion Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Grifols
    • 13.1.1 Grifols Company Details
    • 13.1.2 Grifols Business Overview
    • 13.1.3 Grifols Blood Transfusion Diagnostics Introduction
    • 13.1.4 Grifols Revenue in Blood Transfusion Diagnostics Business (2015-2020))
    • 13.1.5 Grifols Recent Development
  • 13.2 Thermo Fisher Scientific
    • 13.2.1 Thermo Fisher Scientific Company Details
    • 13.2.2 Thermo Fisher Scientific Business Overview
    • 13.2.3 Thermo Fisher Scientific Blood Transfusion Diagnostics Introduction
    • 13.2.4 Thermo Fisher Scientific Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 13.2.5 Thermo Fisher Scientific Recent Development
  • 13.3 Roche
    • 13.3.1 Roche Company Details
    • 13.3.2 Roche Business Overview
    • 13.3.3 Roche Blood Transfusion Diagnostics Introduction
    • 13.3.4 Roche Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 13.3.5 Roche Recent Development
  • 13.4 bioMérieux
    • 13.4.1 bioMérieux Company Details
    • 13.4.2 bioMérieux Business Overview
    • 13.4.3 bioMérieux Blood Transfusion Diagnostics Introduction
    • 13.4.4 bioMérieux Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 13.4.5 bioMérieux Recent Development
  • 13.5 Bio-Rad
    • 13.5.1 Bio-Rad Company Details
    • 13.5.2 Bio-Rad Business Overview
    • 13.5.3 Bio-Rad Blood Transfusion Diagnostics Introduction
    • 13.5.4 Bio-Rad Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 13.5.5 Bio-Rad Recent Development
  • 13.6 Ortho Clinical Diagnostics
    • 13.6.1 Ortho Clinical Diagnostics Company Details
    • 13.6.2 Ortho Clinical Diagnostics Business Overview
    • 13.6.3 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Introduction
    • 13.6.4 Ortho Clinical Diagnostics Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 13.6.5 Ortho Clinical Diagnostics Recent Development
  • 13.7 Becton Dickinson
    • 13.7.1 Becton Dickinson Company Details
    • 13.7.2 Becton Dickinson Business Overview
    • 13.7.3 Becton Dickinson Blood Transfusion Diagnostics Introduction
    • 13.7.4 Becton Dickinson Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 13.7.5 Becton Dickinson Recent Development
  • 13.8 Fujirebio
    • 13.8.1 Fujirebio Company Details
    • 13.8.2 Fujirebio Business Overview
    • 13.8.3 Fujirebio Blood Transfusion Diagnostics Introduction
    • 13.8.4 Fujirebio Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 13.8.5 Fujirebio Recent Development
  • 13.9 DiaSorin (American Standard Companies)
    • 13.9.1 DiaSorin (American Standard Companies) Company Details
    • 13.9.2 DiaSorin (American Standard Companies) Business Overview
    • 13.9.3 DiaSorin (American Standard Companies) Blood Transfusion Diagnostics Introduction
    • 13.9.4 DiaSorin (American Standard Companies) Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 13.9.5 DiaSorin (American Standard Companies) Recent Development
  • 13.10 Beckman Coulter
    • 13.10.1 Beckman Coulter Company Details
    • 13.10.2 Beckman Coulter Business Overview
    • 13.10.3 Beckman Coulter Blood Transfusion Diagnostics Introduction
    • 13.10.4 Beckman Coulter Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 13.10.5 Beckman Coulter Recent Development
  • 13.11 Diagast
    • 10.11.1 Diagast Company Details
    • 10.11.2 Diagast Business Overview
    • 10.11.3 Diagast Blood Transfusion Diagnostics Introduction
    • 10.11.4 Diagast Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 10.11.5 Diagast Recent Development
  • 13.12 Abbott
    • 10.12.1 Abbott Company Details
    • 10.12.2 Abbott Business Overview
    • 10.12.3 Abbott Blood Transfusion Diagnostics Introduction
    • 10.12.4 Abbott Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 10.12.5 Abbott Recent Development
  • 13.13 BAG Health Care
    • 10.13.1 BAG Health Care Company Details
    • 10.13.2 BAG Health Care Business Overview
    • 10.13.3 BAG Health Care Blood Transfusion Diagnostics Introduction
    • 10.13.4 BAG Health Care Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 10.13.5 BAG Health Care Recent Development
  • 13.14 Quidel
    • 10.14.1 Quidel Company Details
    • 10.14.2 Quidel Business Overview
    • 10.14.3 Quidel Blood Transfusion Diagnostics Introduction
    • 10.14.4 Quidel Revenue in Blood Transfusion Diagnostics Business (2015-2020)
    • 10.14.5 Quidel Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Blood Transfusion Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Blood Transfusion Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Grifols
    Thermo Fisher Scientific
    Roche
    bioMérieux
    Bio-Rad
    Ortho Clinical Diagnostics
    Becton Dickinson
    Fujirebio
    DiaSorin (American Standard Companies)
    Beckman Coulter
    Diagast
    Abbott
    BAG Health Care
    Quidel

    Market segment by Type, the product can be split into
    ELISA
    NAT
    Western Blot Assays
    Fluorescence Assay
    Other Technology
    Market segment by Application, split into
    Hospitals
    Clinics
    Blood Banks
    Laboratories
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now